Why KRYS? Krystal Biotech, Inc. Analysis, Price & AI Insights | Whystock
KRYS
$305.71+9.01 (+3.04%)
Market ClosedLast close May 8
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.